Provider’s Clinical Support System—Medication Assisted Treatment Grant
The purpose of this program is to expand the number of Drug Addiction Treatment Act (DATA) 2000 waived providers, increase understanding of the importance of medication-assisted treatment and ultimately increase access to MAT through expanded prescribing of FDA-approved medications for the treatment of opioid use disorders.
SAMHSA plans to issue 1 grant of up to $2,000,000 per year for up to 3 years.
Application Due Date: Tuesday, February 26, 2019
No hay comentarios:
Publicar un comentario